15 drug(s) with this reaction
14,048 total reports
Alopecia has been reported as an adverse reaction across 15 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 14,048 adverse event reports mention alopecia in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with alopecia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have alopecia listed in their FDA adverse event reports, sorted by report count:
In addition to alopecia, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
15 drug(s) manufactured by Haleon Us Holdings Llc have alopecia listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
There are a combined 14,048 reports of alopecia across 15 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.